RecruitingNot ApplicableNCT04039763

RT-CGM in Young Adults at Risk of DKA

Assessment of the Impact of Real-time Continuous Glucose Monitoring on Glycaemic Control in High-risk Adolescents and Young Adults With Insulin-treated Diabetes

Sponsor

Imperial College London

Enrollment

20 participants

Start Date

Sep 3, 2020

Study Type

INTERVENTIONAL

Conditions

Diabetes Mellitus Metabolic Disease Diabetes Mellitus, Type 1 Endocrine System Diseases Autoimmune Diseases Glucose Metabolism Disorders

Summary

Pilot study to evaluate the effect of real time continuous glucose monitoring (RT-CGM) on young-adults with insulin-treated diabetes, who are defined as high risk due to suboptimal HbA1c (blood glucose control) or a history of hospital admissions for high blood glucoses. Hypothesis: RT-CGM provided to young adults with suboptimal blood glucose control, has a beneficial impact on HbA1c and hospital admissions for high blood glucoses. We will use data from this pilot work to inform a larger powered study to address this knowledge gap.

Eligibility

Min Age: 18 YearsMax Age: 25 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether using a real-time continuous glucose monitor (CGM) — a wearable sensor that constantly tracks blood sugar — can help young adults with type 1 diabetes avoid a dangerous complication called diabetic ketoacidosis (DKA), where blood sugar spins dangerously out of control. **You may be eligible if...** - You are a young adult (typically 18-25) with type 1 diabetes - You are considered at higher risk of DKA based on your history - You are not already using a continuous glucose monitor regularly **You may NOT be eligible if...** - You are already using a CGM device - You have other medical conditions that interfere with glucose monitoring - You are not able to use the device as instructed Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.